Actinium Pharmaceuticals (ATNM) Q4 2024 Earnings

14NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.51
-0.44
-0.38
-0.31

Details

Expected EPS
-0.385
Actual EPS
-0.37
Surprise EPS
0.02
Surprise Percent
+3.9%

Description

Actinium Pharmaceuticals (ATNM) has reported earnings of -0.37 per share for Q4 2024.

0 Comments

Share your thoughts